KFDA approves simvastatin CR’s intake anytime

Hanmi Pharm says it has received approval from the Korea Food and Drug Administration to administer simvastatin controlled release (CR) tablet without restriction in the morning or at night.

For simvastatin, the evidence is that marginally better lowering of total and LDL cholesterol comes from taking the tablets in the evening than in the morning.

Simvastatin is best taken at night, whe...